Posted on 24/11/2009 in Medical Company Financials Medtronic has revealed its financial results for the second fiscal quarter of 2010, which show that the firm saw revenue growth of six per cent during the period, compared to the correlating time of the 2009 year.
The company's revenue for the quarter hit $3.838 billion (2.324 billion pounds) - representing an increase from the $3.570 billion reported during the same time last year.
Its reported second-quarter net earnings were $868 million - the equivalent of $0.78 per diluted share.
Bill Hawkins, Medtronic's chairman and chief executive officer, commented: "We are well-positioned to deliver on our commitments for the balance of our fiscal year and to launch innovative new products to drive further growth in the coming years."
Earlier this month, Medtronic announced that it had launched a new clinical trial into its Attain instruments - which include the Attain StarFix and the Attain Ability left-heart leads.
Other news stories from 24/11/2009
Read more in the Zenopa News Archive
How this news is generated
|
